Cargando…

The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin

Detalles Bibliográficos
Autores principales: Geserick, P, Wang, J, Feoktistova, M, Leverkus, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385933/
https://www.ncbi.nlm.nih.gov/pubmed/25741598
http://dx.doi.org/10.1038/cddis.2015.55
_version_ 1782365109830549504
author Geserick, P
Wang, J
Feoktistova, M
Leverkus, M
author_facet Geserick, P
Wang, J
Feoktistova, M
Leverkus, M
author_sort Geserick, P
collection PubMed
description
format Online
Article
Text
id pubmed-4385933
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43859332015-04-07 The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin Geserick, P Wang, J Feoktistova, M Leverkus, M Cell Death Dis Corrigendum Nature Publishing Group 2015-03 2015-03-05 /pmc/articles/PMC4385933/ /pubmed/25741598 http://dx.doi.org/10.1038/cddis.2015.55 Text en Copyright © 2015 Macmillan Publishers Limited
spellingShingle Corrigendum
Geserick, P
Wang, J
Feoktistova, M
Leverkus, M
The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
title The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
title_full The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
title_fullStr The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
title_full_unstemmed The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
title_short The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
title_sort ratio of mcl-1 and noxa determines abt737 resistance in squamous cell carcinoma of the skin
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385933/
https://www.ncbi.nlm.nih.gov/pubmed/25741598
http://dx.doi.org/10.1038/cddis.2015.55
work_keys_str_mv AT geserickp theratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin
AT wangj theratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin
AT feoktistovam theratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin
AT leverkusm theratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin
AT geserickp ratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin
AT wangj ratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin
AT feoktistovam ratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin
AT leverkusm ratioofmcl1andnoxadeterminesabt737resistanceinsquamouscellcarcinomaoftheskin